
Asthenic syndrome: new challenges – a new approach
Author(s) -
O. M. Barna,
M. A. Kalinichenko
Publication year - 2021
Publication title -
lìki ukraïni
Language(s) - English
Resource type - Journals
ISSN - 1997-9894
DOI - 10.37987/1997-9894.2021.4(250).238120
Subject(s) - specialty , pharmacotherapy , medicine , psychotherapist , psychiatry , intensive care medicine , psychology
Today, asthenia is one of the most common syndromes in the practice of a doctor of any specialty. Her treatment uses a comprehensive approach that includes physical training, psychotherapy, diet and pharmacotherapy. Pharmacotherapeutic treatment of asthenia includes the appointment of antidepressants, nootropics, tranquilizers, psychostimulants, neuroleptics. Given the multimodality and multilevel nature of the lesion of the nervous system in CОVID-19, in the recovery period, it is advisable to prescribe complex drugs with a wide range of therapeutic possibilities. The use of herbal drugs, in particular Vazavital Neuro and Cardiolin, is considered promising.